ESR1 and breast carcinoma: In consideration of a strong correlation between stage level and RFS, we analyzed the proportion of high-risk samples identified by the signature in each stage rather than carrying out the survival analysis to test 5-GPS on the RNA-Seq data of 633 female ER+ stage I-IV breast cancer samples from TCGA.